Role of Foxp3-positive regulatory T cells during infection - PubMed (original) (raw)
Review
Role of Foxp3-positive regulatory T cells during infection
Yasmine Belkaid. Eur J Immunol. 2008 Apr.
Abstract
Surviving an infection requires the generation of an immune response that controls the invading pathogen while limiting collateral damage to self tissues that may result from an exuberant immune response. Various populations of regulatory cells, including Foxp3+ Treg, have been shown to play a central role in the establishment of these controlled immune responses. In this review, I discuss current hypotheses and points of polemic associated with the origin, mode of action and antigen specificity of Foxp3+ Treg during infection.
Conflict of interest statement
Conflict of interest: The authors declare no financial or commercial conflict of interest.
Figures
Figure 1
Foxp3+ Treg accumulate at sites of Leishmania infection. TCR−/− mice were injected with CD4+CD25− T cells from cyan fluorescent protein-expressing transgenic mice and CD4+Foxp3+ Treg from Foxp3-GFP-knock-in mice. Leishmania expressing red fluorescent protein were injected intra-dermally into the ear. This image was taken at 1 month post-infection (red: Leishmania; cyan: CD4+CD25− T cells; green: CD4+Foxp3+ Treg). dysregulation of Treg function requires further analysis.
Figure 2
Origins and specificities of Treg during infections. The origin and antigen specificity of Treg may vary according to the site and the nature of the infection. In acute infection, tissue damage may be associated with enhanced presentation of self antigens. In this case, self-reactive natural Treg may be activated and could, in a bystander manner, limit effector responses against the pathogen. At sites of infection various populations of microbe-specific Treg can be induced (e.g. converted Foxp3+ Treg (cFoxp3+), Th1 cells producing IL-10 or inducible T reg (Tr1 cells)). In some chronic infections, there is evidence that natural Treg may also accumulate at sites of infection and can recognize microbial antigens. In an environment that is rich in TGF-β and the vitamin A metabolite retinoic acid (RA), such as the gut, peripheral conversion of Foxp3− T cells into Foxp3+ Treg may occur in response to food or gut flora antigen or during oral infection. These converted Foxp3+ T cells could potentially limit immune responses. Some of these converted cells may be able to recirculate and could contribute to the control of peripheral homeostasis. Red arrows indicate control of immune responses.
Similar articles
- Regulatory T cells in the control of host-microorganism interactions (*).
Belkaid Y, Tarbell K. Belkaid Y, et al. Annu Rev Immunol. 2009;27:551-89. doi: 10.1146/annurev.immunol.021908.132723. Annu Rev Immunol. 2009. PMID: 19302048 Review. - Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.
Vocanson M, Rozieres A, Hennino A, Poyet G, Gaillard V, Renaudineau S, Achachi A, Benetiere J, Kaiserlian D, Dubois B, Nicolas JF. Vocanson M, et al. J Allergy Clin Immunol. 2010 Aug;126(2):280-9, 289.e1-7. doi: 10.1016/j.jaci.2010.05.022. Epub 2010 Jul 10. J Allergy Clin Immunol. 2010. PMID: 20624644 - Role of endogenous and induced regulatory T cells during infections.
Wohlfert E, Belkaid Y. Wohlfert E, et al. J Clin Immunol. 2008 Nov;28(6):707-15. doi: 10.1007/s10875-008-9248-6. Epub 2008 Sep 23. J Clin Immunol. 2008. PMID: 18810611 Free PMC article. Review. - The mechanisms shaping the repertoire of CD4+ Foxp3+ regulatory T cells.
Kraj P, Ignatowicz L. Kraj P, et al. Immunology. 2018 Mar;153(3):290-296. doi: 10.1111/imm.12859. Epub 2017 Nov 22. Immunology. 2018. PMID: 29106696 Free PMC article. Review. - Foxp3 Instability Helps tTregs Distinguish Self and Non-self.
Zhang Z, Zhou X. Zhang Z, et al. Front Immunol. 2019 Sep 24;10:2226. doi: 10.3389/fimmu.2019.02226. eCollection 2019. Front Immunol. 2019. PMID: 31608056 Free PMC article. Review.
Cited by
- Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models.
Seyran M, Melanie S, Philip S, Amiq G, Fabian B. Seyran M, et al. Clin Exp Med. 2023 Aug;23(4):1075-1088. doi: 10.1007/s10238-022-00945-7. Epub 2022 Nov 20. Clin Exp Med. 2023. PMID: 36403186 Free PMC article. Review. - Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.
Liu J, Yang X, Wang H, Li Z, Deng H, Liu J, Xiong S, He J, Feng X, Guo C, Wang W, Zelinskyy G, Trilling M, Sutter K, Senff T, Menne C, Timm J, Zhang Y, Deng F, Lu Y, Wu J, Lu M, Yang D, Dittmer U, Wang B, Zheng X. Liu J, et al. mBio. 2021 Apr 27;12(2):e00085-21. doi: 10.1128/mBio.00085-21. mBio. 2021. PMID: 33906918 Free PMC article. - Regulatory T cells in skin injury: At the crossroads of tolerance and tissue repair.
Boothby IC, Cohen JN, Rosenblum MD. Boothby IC, et al. Sci Immunol. 2020 May 1;5(47):eaaz9631. doi: 10.1126/sciimmunol.aaz9631. Sci Immunol. 2020. PMID: 32358172 Free PMC article. Review. - Regulatory T Cells Beyond Autoimmunity: From Pregnancy to Cancer and Cardiovascular Disease.
Martini E, Giugliano S, Rescigno M, Kallikourdis M. Martini E, et al. Front Immunol. 2020 Mar 31;11:509. doi: 10.3389/fimmu.2020.00509. eCollection 2020. Front Immunol. 2020. PMID: 32296427 Free PMC article. Review. - Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.
David P, Drabczyk-Pluta M, Pastille E, Knuschke T, Werner T, Honke N, Megger DA, Akhmetzyanova I, Shaabani N, Eyking-Singer A, Cario E, Kershaw O, Gruber AD, Tenbusch M, Dietze KK, Trilling M, Liu J, Schadendorf D, Streeck H, Lang KS, Xie Y, Zimmer L, Sitek B, Paschen A, Westendorf AM, Dittmer U, Zelinskyy G. David P, et al. PLoS Pathog. 2020 Mar 30;16(3):e1008340. doi: 10.1371/journal.ppat.1008340. eCollection 2020 Mar. PLoS Pathog. 2020. PMID: 32226027 Free PMC article.
References
- Shevach EM, et al. Immunol Rev. 2006;212:60–73. - PubMed
- Powrie F, et al. Novartis Found Symp. 2003;252:92–98. - PubMed
- Suvas S, et al. J Immunol. 2004;172:4123–4132. - PubMed
- Hesse M, et al. J Immunol. 2004;172:3157–3166. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources